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Brown tumors are bony lesions triggered by rapid osteoclastic activity, which rarely involved jaws (1-3). In fact brown tumors or osteoclastomas 
are erosive bony lesions appearing as a complication 
of hyperparathyroidism. Renal osteodystrophy is 
the result of secondary hyperparathyroidism and is 
associated with various pathogenetic mechanisms, such 
as disorder of calcium-phosphate metabolism, increased 
parathyroid activity that lead to extreme concentrations 
of parathormone and impaired metabolism of 
vitamin D (1-7).
We report a case of jaw enlargement in a 28-year-old 
patient with a ten years history of urinary obstruction 
due to multiple renal stones and history of chronic renal 
failure detected by laboratory records. One year before 
admission, the patient underwent bilateral DJ insertion. 
At the admission, patient had a GFR of 30 cc/min and low 
bilateral kidney size.
Three years before admission, isotopic renal scintigraphy 
revealed a severely decreased function (around 8%) of 
right kidney and around 10% reduced function of left 
kidney. A 66×23 mm of right kidney size and a 150×65 
mm of left renal size with sever hydronephrosis, by 
sonography was detected.
According to the low kidney size, patients was not 
scheduled for renal biopsy and treatment with enalapril; 
20 mg/day, allopurinol 50 mg/day and atorvastatin 10 mg/
daily was started.
Two months after, patients returned to nephrology 
clinic with a new complain of jaw protrusion (Figure 1) 
which was supported by a cystic lesion of the jaw in MRI 
(Figure 2).
A conducted mandibular, anterior side incisional biopsy, 
detected a giant cell lesion with no evidence of malignancy. 
The result of laboratory test was as the follow;
Serum creatinine; 3.9 mg/dl, intact PTH; 119 (10.9-54.8) 
ρg/ml, calcium; 8.2 mg/dl, phosphorus 5 mg/dl and 
alkaline phosphatase was 466 IU/l. Vitamin D level; 35 
ng/ml and serum calcitonine was 16.4 (0.2-27.7) ρg/ml. 
Patient was decided to treat firstly by cinacalcet and then 
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Figure 1. Brown tumor of the jaw due to secondary 
hyperparathyroidism. A, B; Jaw protrusion. C; dental displacing 
by tumor.
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we decided to refer him for surgical repair of teeth and 
tumor.
In patients with end-stage kidney failure, brown tumors 
are uncommon skeletal manifestations (1-5). Brown 
tumors are tumors of the bone that happen due to 
augmented osteoclastic activity, which are usually seen 
in severe forms of secondary hyperparathyroidism 
(5-8). Secondary hyperparathyroidism, which develops 
from phosphate retention and impaired calcitriol 
(1,25-dihyroxyvitamin D3) synthesis in end-stage kidney 
failure, can cause increased osteoclastic activity, which may 
emerge as cysts in the bone and may ultimately progress to 
represent as brown tumors if left untreated (8-10). Brown 
tumors are defined in 1.5%–1.7% of patients with chronic 
kidney disease and happen most often in the pelvis, ribs, 
and mandible (7-12). Initial management involves the 
correction of hyperparathyroidism, which usually results 
to regression of the tumors (6-12).
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Figure 1. Cystic lesion of the jaw
